Dissecting HDAC3-mediated tumor progression.
Mariadason
John M
JM
Albert Einstein College of Medicine, Department of Oncology, Montefiore Medical Center, Bronx, NY 10467, USA. jmariada@aecom.yu.edu
D000818:Animals; D018450:Disease Progression; D004791:Enzyme Inhibitors / Q000494:pharmacology; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006655:Histone Deacetylases / Q000378:metabolism* / Q000502:physiology*; D006801:Humans; D016399:Lymphoma, T-Cell / Q000628:therapy; D008495:Medical Oncology / Q000379:methods; D051379:Mice; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D014157:Transcription Factors / Q000378:metabolism; D000099186:Histone Deacetylase 3
D004791:Enzyme Inhibitors; D006655:Histone Deacetylases; D014157:Transcription Factors; D000099186:Histone Deacetylase 3
Clin Cancer Res. 2008 Mar 15;14(6):1669-77
18347167
J Nutr. 2005 Nov;135(11):2710-4
16251635
PLoS Genet. 2008 Feb 29;4(2):e1000009
18454196
Mol Biol Cell. 2008 Oct;19(10):4062-75
18632985
Proc Nutr Soc. 2008 May;67(2):115-27
18412986
Science. 2001 Aug 31;293(5535):1653-7
11533489
Mol Cell Biol. 2007 Feb;27(4):1280-95
17158926
Mol Cell. 2008 Apr 11;30(1):61-72
18406327
Oncogene. 2004 Sep 2;23(40):6712-25
15300237
Nat Med. 2004 Sep;10(9):917-9
15322538
J Biol Chem. 2006 May 12;281(19):13548-13558
16533812
Mol Carcinog. 2008 Feb;47(2):137-47
17849419
Biochem Biophys Res Commun. 2006 Jan 6;339(1):165-71
16298343
Cancer Biol Ther. 2008 Oct;7(10):1570-80
18769117
Epigenetics. 2008 Jan-Feb;3(1):28-37
18326939